Carl Beyer Selected Research

HTI 042

9/2004

Synthesis and biological activity of analogues of the antimicrotubule agent N,beta,beta-trimethyl-L-phenylalanyl-N(1)-[(1S,2E)-3-carboxy-1-isopropylbut-2-enyl]- N(1),3-dimethyl-L-valinamide (HTI-286).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carl Beyer Research Topics

Disease

6	Neoplasms (Cancer) 01/2009 - 04/2003
1	Hyperkalemia 12/2018
1	Nonpenetrating Wounds 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Multiple Trauma (Multiple Injuries) 01/2017
1	Carcinoma (Carcinomatosis) 04/2003

Drug/Important Bio-Agent (IBA)

4	Paclitaxel (Taxol)FDA LinkGeneric 06/2006 - 04/2003
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2005 - 04/2003
2	Docetaxel (Taxotere)FDA Link 06/2006 - 09/2003
2	HTI-286IBA 05/2005 - 04/2003
1	PotassiumIBA 12/2018
1	compound 21IBA 01/2009
1	PyrimidinesIBA 01/2009
1	taxaneIBA 06/2006
1	MST 997IBA 06/2006
1	hemiasterlinIBA 05/2005
1	HTI 042IBA 09/2004
1	Taxoids (Taxanes)IBA 09/2003
1	MAC321IBA 09/2003
1	Vincristine (Oncovin)FDA LinkGeneric 04/2003

Therapy/Procedure

1	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2018
1	Hemoperfusion 12/2018
1	Nephrectomy 01/2017
1	Therapeutics 01/2017
1	Splenectomy 01/2017